NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
This grant funds small businesses to support innovative research and development projects that have the potential for commercialization.
About this program
The NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award is designed to provide funding to small businesses that are working on innovative research and development projects. This grant is particularly aimed at projects that have already demonstrated feasibility and are ready to move towards commercialization. The funding can be used to support further development, testing, and validation of the product or service being developed. Eligible applicants include small businesses that meet the criteria set forth by the NIH. The grant is intended for businesses that are focused on health-related research and development, and it encourages collaboration with research institutions and other partners. The Phase IIB award is particularly beneficial for businesses that have previously received Phase I or Phase II SBIR funding and are looking to expand their research efforts and bring their innovations to market.
Eligibility
Small businesses engaged in health-related research and development.
Requirements
- Must be a small business
- Must have previously received Phase I or Phase II SBIR funding